Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This was a randomized, single-blind, two-period, two sequence cross-over study under fasting
condition, with a one-week wash-out period, to compare the pharmacokinetic profiles and
bioavailability of two formulations (the test and reference) of valsartan 160 mg film-coated
caplets.